Authors:
Saitoh, M
Aye, NN
Komori, S
Nakazawa, T
Hashimoto, K
Citation: M. Saitoh et al., Effects of HNS-32, a novel antiarrhythmic drug, on ventricular arrhythmiasinduced by coronary artery occlusion and reperfusion in anesthetized rats, MOL C BIOCH, 205(1-2), 2000, pp. 133-140
Authors:
Sugiyama, A
Aye, NN
Yatomi, Y
Ozaki, Y
Hashimoto, K
Citation: A. Sugiyama et al., Effects of sphingosine 1-phosphate, a naturally occurring biologically active lysophospholipid, on the rat cardiovascular system, JPN J PHARM, 82(4), 2000, pp. 338-342
Authors:
Miyamoto, S
Zhu, BM
Teramatsu, T
Aye, NN
Hashimoto, K
Citation: S. Miyamoto et al., QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide, EUR J PHARM, 400(2-3), 2000, pp. 263-269
Authors:
Sugiyama, A
Aye, NN
Sawada, N
Hashimoto, K
Citation: A. Sugiyama et al., Cariporide, a highly selective Na+/H+ exchange inhibitor, suppresses the reperfusion-induced lethal arrhythmias and "overshoot" phenomenon of creatine phosphate in situ rat heart, J CARDIO PH, 33(1), 1999, pp. 116-121
Citation: Nn. Aye et al., Effects and interaction, of cariporide and preconditioning on cardiac arrhythmias and infarction in rat in vivo, BR J PHARM, 127(4), 1999, pp. 1048-1055
Citation: Yx. Xue et al., Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide, N-S ARCH PH, 358(6), 1998, pp. 649-656